1674973: ADENOSINE INJECTION.
The ADENOSINE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, features_provided: STERILE, primary_container_type: VIAL, secondary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-724-4068, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| features_provided | STERILE |
| primary_container_type | VIAL |
| secondary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 2.0 MILLILITERS |
| active_medicament_medicinal_strength | 3.0 MILLIGRAMS ADENOSINE PER MILLILITER |
| part_name_assigned_by_controlling_agency | ADENOSINE INTRAVENOUS SOLUTION, 2ML VIAL, 3 MG/ML, 10S |
| NSN | 6505-01-724-4068 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.0 MILLILITERS |
| SECONDARY CONTAINER TYPE | VIAL |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | INDICATED INTRAVENOUSLY FOR THE CONVERSION TO SINUS RHYTHM OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT), INCLUDING THAT ASSOCIATED WITH ACCESSORY BYPASS TRACTS (WOLFF-PARKINSON-WHITE SYNDROME). ADENOSINE INJECTION, USP DOES NOT CONVERT ATRIAL FLUTTER, ATRIAL FIBRILLATION, OR VENTRICULAR TACHYCARDIA TO NORMAL SINUS RHYTHM; FOR RAPID BOLUS INTRAVENOUS USE; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); DO NOT REFRIGERATE; CONTAINS NO PRESERVATIVES; DISCARD UNUSED PORTION; CONTAINER CLOSURE IS NOT MADE WITH NATURAL RUBBER LATEX; CONTAINS 10 VIALS, 2ML SINGLE DOSE VIAL; SUPPLIED AS A STERILE, NONPYROGENIC SOLUTION IN NORMAL SALINE. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ADENOSINE INTRAVENOUS SOLUTION, 2ML VIAL, 3 MG/ML, 10S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.0 MILLIGRAMS ADENOSINE PER MILLILITER |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |